105 related articles for article (PubMed ID: 970488)
1. Importance of dopamine metabolism for clinical effects and side effects of neuroleptics.
Van Praag HM; Korf J
Am J Psychiatry; 1976 Oct; 133(10):1171-7. PubMed ID: 970488
[TBL] [Abstract][Full Text] [Related]
2. Hypokinetic-rigid extrapyramidal side effects of neuroleptics: the relationship of the silent period in EMG and HVA and 5-HIAA in CSF.
Yazici O; Hizal A; Eroğlu L; Baslo A; Yazici J
J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):448-50. PubMed ID: 2422327
[TBL] [Abstract][Full Text] [Related]
3. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
Kazamatsuri H; Chien C; Cole JO
Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
[No Abstract] [Full Text] [Related]
4. The neuroleptics. 10. Therapeutic problems.
Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
[No Abstract] [Full Text] [Related]
5. Therapeutic approaches to tardive dyskinesia. A review of the literature.
Kazamatsuri H; Chien C; Cole JO
Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
[No Abstract] [Full Text] [Related]
6. Neuroleptics, catecholamines, and psychoses: a study of their interrelations.
Van Praag HM; Korf J
Am J Psychiatry; 1975 Jun; 132(6):593-7. PubMed ID: 235848
[TBL] [Abstract][Full Text] [Related]
7. [Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
Caroli F; Littre-Poirier MF; Ginestet D; Deniker P
Encephale; 1975; 1(1):69-74. PubMed ID: 805695
[TBL] [Abstract][Full Text] [Related]
8. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
Huygens H; Vereecken JL; Tanghe A
Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
[No Abstract] [Full Text] [Related]
9. Basic principles of rapid neuroleptization.
Mason AS; Granacher RP
Dis Nerv Syst; 1976 Oct; 37(10):547-51. PubMed ID: 9267
[No Abstract] [Full Text] [Related]
10. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
Bourgeois M; Bouey P
Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
[No Abstract] [Full Text] [Related]
11. [Cellular effect of neuroleptics].
Kuschinsky K
Dtsch Med Wochenschr; 1975 Jun; 100(25):1405-8. PubMed ID: 237751
[No Abstract] [Full Text] [Related]
12. The significance of dopamine for the mode of action of neuroleptics and the pathogenesis of schizophrenia.
van Praag HM
Br J Psychiatry; 1977 May; 130():463-74. PubMed ID: 861426
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
Kazamatsuri H; Chien C; Cole JO
Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
[No Abstract] [Full Text] [Related]
14. Neuroleptic induced extrapyramidal symptoms.
Donlon PT; Stenson RL
Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
[TBL] [Abstract][Full Text] [Related]
15. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
Predescu V; Nica-Udangiu St
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(4):287-96. PubMed ID: 1085475
[No Abstract] [Full Text] [Related]
16. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
Molcan J; Floreánová L; Polák L
Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
[No Abstract] [Full Text] [Related]
17. On the interaction between neuroleptics and antiparkinson drugs.
Julou L
Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
[No Abstract] [Full Text] [Related]
18. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
Kazamatsuri H; Chien CP; Cole JO
Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
[No Abstract] [Full Text] [Related]
19. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
Singh MM; Smith JM
J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
[No Abstract] [Full Text] [Related]
20. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
Lambert A; dachary JM; Marie C; Oules J; Pagot R; Sales M; Vauterin C
Encephale; 1976; 2(2):115-21. PubMed ID: 776591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
